Clinical Trials
21 trialsNCT07478848 2026-05-22
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Abramson Cancer Center at Penn Medicine
Phase 1 Not yet recruiting
NCT07590648 2026-05-15
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
Phase 4 Not yet recruiting
NCT03030248 2026-04-15
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Medical College of Wisconsin
Phase 2 Completed
NCT07220967 2026-04-09
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
Memorial Sloan Kettering Cancer Center
Phase 4 Recruiting
NCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04948463 2026-03-20
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
NCT03785210 2026-02-23
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT03546829 2026-01-14
Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Recruiting
NCT04729322 2025-12-23
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06126731 2025-11-24
Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Institute of Cancer Research, United Kingdom
Phase 1/2 Recruiting
NCT04208958 2025-10-27
ConsortiumIO
Vedanta Biosciences, Inc.
Phase 1/2 Completed
NCT06540391 2025-09-26
MELODY-1
Microbiotica Ltd
Phase 1 Active not recruiting
NCT05690048 2025-08-06
FLORA
University Hospital Heidelberg
Phase 2 Recruiting
NCT04025567 2020-03-16
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT00296049 2018-08-10
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT02732327 2017-07-21
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Forest Laboratories
Phase 2 Terminated
NCT02463747 2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT00003805 2012-09-24
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00529282 2012-08-01
A Study of Ceftobiprole in Patients With Fever and Neutropenia.
Basilea Pharmaceutica
Phase 3 Terminated
NCT00035425 2009-12-01
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Pfizer
Phase 3 Completed
NCT00454272 2009-03-06
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Sanofi
Phase 4 Completed